Table 2.
Author | Patients | Complications donor site | Infection | Fracture | Nonunion | Failure | Reconstruction survival |
---|---|---|---|---|---|---|---|
Presented results | 12 | 2 in 2 pat | 2 (16.6%) | 4 (33.3%) | 4 (33.3%) | 0 | 100% at ~3.5 years |
Capanna et al. [30] | 90 | n.s | 7 (7.5%) | 12 (13.3%) | 8 (8.8%) | 6 (6.5%) | 93.3% at ~9 years |
Li et al. [32] | 11 | 10 in 5 pat | 0 | 0 | 1 (9%) | 1 (9%) | 90.9% at ~2.8 years |
Jager et al. [33] | 7 | 7 in 6 pat | 1 (14.28%) | 1 (14.28%) | 2 (28.5%) | 0 | 100% at ~3.7 years |
Li et al. [31] | 8 | 4 in 2 pat | 0 | 0 | 2 (25%) | 1 (12.5%) | 87.5% at ~3.2 years |
Innocenti et al. [34] | 21 | 5 in 4 pat | 1 (4.7%) | 6 (28.5%) | 2 (9.5%) | 4 (19%) | 80.9% at 10 years |
Abed et al. [35] | 25 | 6 in 5 pat | 1 (4%) | 9 (36%) | 1 (4%) | 5 (20%) | 79% at 5 years |
Moran et al. [36] | 7 | 1 in 1 pat | 0 | 2 (28.6%) | 2 (28.5%) | 0 | 100% at ~4.3 years |
Bernd et al. [37] | 16 | 1 in 1 pat | 2 (12.5%) | 1 (6.25%) | 5 (31.3%) | 1 (6.3%) | 93.75% at ~5 years |
Hennen et al. [38] | 10 | 0 | 1 (10%) | 0 | 1 (10%) | 2 (20%) | 80% at ~2.6 years |
Ozaki et al. [39] | 12 | n.s | 0 | 4 (33%) | n.s | 0 | 100% at ~2.6 years |
n.s: not specified; Percentages in brackets.